GO:0044602 protein deadenylylation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0044602 protein deadenylylation is the enzymatic removal of an adenylyl group (AMP) from a protein amino acid, reversing protein adenylylation.
• The process was first discovered in bacteria as part of the glutamine synthetase cascade, where deadenylylation activates glutamine synthetase.
• Deadenylylation is tightly regulated by the PII signal transduction protein, whose uridylylation state controls the opposing adenylyltransferase/deadenylyltransferase activities.
• In eukaryotes, deadenylylation of mRNA is a distinct but related process; protein deadenylylation remains less studied but is implicated in cellular signaling.
• Key enzymes include the bifunctional adenylyltransferase (GlnE) in bacteria, which catalyzes both adenylylation and deadenylylation via distinct domains.
• Dysregulation of deadenylylation can affect nitrogen metabolism and may contribute to diseases such as cancer and metabolic disorders.
Description
Protein deadenylylation (GO:0044602) is a post-translational modification that removes an adenylyl group (adenosine 5'-monophosphate; AMP) from a protein amino acid, thereby reversing the effects of protein adenylylation. This process was first characterized in bacteria as a key step in the regulation of glutamine synthetase, an enzyme central to nitrogen assimilation. The discovery of deadenylylation revealed a novel mechanism of enzyme regulation that involves reversible covalent modification, analogous to phosphorylation but using AMP as the modifying group. In recent years, protein deadenylylation has gained attention as a potential regulatory mechanism in eukaryotic cells, although its full scope remains to be elucidated. Understanding protein deadenylylation is crucial for researchers studying bacterial nitrogen metabolism, signal transduction, and the broader field of post-translational modifications.
protein deadenylylation At A Glance
| GO ID | GO:0044602 |
|---|---|
| GO term | protein deadenylylation |
| Ontology | biological_process |
| Synonym | protein deAMPylation |
| Major function | Removal of AMP from proteins, reversing adenylylation |
| Key enzymes | Adenylyltransferase/deadenylyltransferase (e.g., GlnE), PII regulatory protein |
| Regulation | Modulated by PII uridylylation and metabolic signals |
| Organisms | Bacteria (E. coli, Klebsiella), eukaryotes (mammals) |
What Is GO:0044602?
Protein deadenylylation is the biological process in which an adenylyl group (AMP) is enzymatically removed from a protein amino acid residue. This reaction is the reverse of protein adenylylation and is catalyzed by specific deadenylylating enzymes. The process was originally discovered in the context of glutamine synthetase regulation in enterobacteria, where deadenylylation activates the enzyme under nitrogen-rich conditions.
Why Is protein deadenylylation Important in Cell Biology?
Protein deadenylylation is a critical regulatory mechanism that allows cells to rapidly adjust enzyme activity in response to changing environmental conditions, particularly nitrogen availability. In bacteria, the deadenylylation of glutamine synthetase is essential for efficient nitrogen assimilation and survival under nitrogen-limiting conditions. The discovery of this process provided a paradigm for reversible covalent modification as a means of metabolic regulation, influencing subsequent research on phosphorylation and other post-translational modifications. In eukaryotes, deadenylylation of proteins may play roles in signal transduction and cellular stress responses, although much remains to be discovered. Understanding protein deadenylylation has implications for biotechnology, infectious disease, and cancer research, as dysregulation of this process can lead to metabolic imbalances and disease.
• Regulates glutamine synthetase activity, a central enzyme in nitrogen metabolism.
• Provides a model for reversible covalent modification in enzyme regulation.
• Involved in bacterial response to nitrogen limitation and excess.
• Potential role in eukaryotic signal transduction and mRNA stability.
• May influence cancer cell metabolism and proliferation.
• Target for antibacterial drug development due to its role in nitrogen assimilation.
• Contributes to the understanding of post-translational modifications beyond phosphorylation.
• Relevant to biotechnology applications in nitrogen fixation and amino acid production.
• Implicated in metabolic disorders and potential neurodegeneration.
• Offers insights into the evolution of signaling pathways.
What Happens During protein deadenylylation?
Recognition of Adenylylated Protein Substrates
In simple terms: The cell identifies proteins that have an AMP tag attached.
The first step in protein deadenylylation is the recognition of target proteins that carry an adenylyl group on a specific amino acid residue, typically a tyrosine or serine. In the bacterial glutamine synthetase system, the adenylylated form of glutamine synthetase is recognized by the deadenylylation system, which includes the PII regulatory protein and the bifunctional adenylyltransferase enzyme. The PII protein senses the cellular nitrogen status and interacts with the adenylyltransferase to stimulate deadenylylation under conditions of nitrogen excess.
Enzymatic Removal of AMP
In simple terms: An enzyme cuts off the AMP tag from the protein.
The actual removal of the adenylyl group is catalyzed by a deadenylyltransferase activity, which in bacteria is part of the bifunctional GlnE enzyme. This enzyme possesses two opposing activities: adenylyltransferase (which adds AMP) and deadenylyltransferase (which removes AMP), residing in distinct homologous domains. The deadenylylation reaction involves the hydrolysis of the phosphodiester bond between the AMP moiety and the protein, releasing free AMP and the unmodified protein. The activity is tightly regulated by the uridylylation state of the PII protein, which in turn reflects the intracellular glutamine and alpha-ketoglutarate levels.
Regulation by PII and Metabolic Signals
In simple terms: The process is turned on or off based on the cell's nitrogen needs.
The PII regulatory protein is central to the control of protein deadenylylation. When nitrogen is abundant, PII is uridylylated, which promotes the deadenylylation of glutamine synthetase, leading to its activation. Conversely, under nitrogen limitation, PII is deuridylylated, favoring adenylylation and inactivation of glutamine synthetase. This regulatory circuit ensures that glutamine synthetase activity is matched to the availability of nitrogen sources. The metabolic transformation of PII is mediated by the enzymes uridylyltransferase and uridylyl-removing enzyme, which respond to glutamine and alpha-ketoglutarate levels.
Consequences for Cellular Metabolism
In simple terms: Removing the AMP tag changes how the protein works.
Deadenylylation of glutamine synthetase leads to its activation, allowing the enzyme to catalyze the synthesis of glutamine from glutamate and ammonia. This is crucial for nitrogen assimilation when nitrogen is plentiful, as it enables the cell to store excess nitrogen in the form of glutamine. In eukaryotic cells, deadenylylation of proteins may alter their stability, localization, or interaction partners, thereby impacting various signaling pathways. The reversibility of adenylylation/deadenylylation allows for rapid adaptation to fluctuating environmental conditions.
Key Genes Involved in GO:0044602 protein deadenylylation
The following genes and proteins are key players in protein deadenylylation, as identified in bacterial and eukaryotic systems.
| Gene | Major Role | Research Relevance |
|---|---|---|
| glnA | Glutamine synthetase; target of adenylylation/deadenylylation | Central to nitrogen metabolism; model substrate for deadenylylation studies |
| glnE | Bifunctional adenylyltransferase/deadenylyltransferase | Catalyzes both addition and removal of AMP; key enzyme for deadenylylation |
| glnB | PII regulatory protein; senses nitrogen status | Regulates GlnE activity via uridylylation; controls deadenylylation |
| glnD | Uridylyltransferase/uridylyl-removing enzyme | Modifies PII; indirectly regulates deadenylylation |
| glnK | PII-like protein; involved in nitrogen regulation | May modulate deadenylylation in some bacteria |
| NtrC | Response regulator; regulates glnA transcription | Affects glutamine synthetase levels; indirect role |
| NtrB | Sensor kinase; phosphorylates NtrC | Upstream regulator of nitrogen response |
| GlnA (eukaryotic) | Glutamine synthetase in mammals | Potential target for deadenylylation; less characterized |
| FICD | Fic domain-containing protein; adenylyltransferase (AMPylation) | May have deadenylylation activity; emerging role in ER stress |
| HYPE | FICD homolog; AMPylates BiP | Potential deadenylylation counterpart; not fully confirmed |
| PII (eukaryotic) | PII-like proteins in plants and mammals | Possible regulators of deadenylylation |
| GlnE homologs | Bacterial bifunctional enzymes | Diverse in bacteria; targets for antibiotic development |
| AMPylases | Enzymes that add AMP to proteins | Counterparts to deadenylylases; balance modification |
| DeAMPylases | Enzymes that remove AMP | Directly catalyze deadenylylation; include GlnE and potential eukaryotic enzymes |
| Glutamine synthetase (plant) | Nitrogen assimilation in plants | May undergo deadenylylation; agricultural relevance |
| Glutamine synthetase (fungal) | Nitrogen regulation in fungi | Similar regulatory mechanisms |
How Is protein deadenylylation Regulated?
Protein deadenylylation is regulated primarily through the PII signal transduction protein, which undergoes reversible uridylylation in response to intracellular glutamine and alpha-ketoglutarate levels. In bacteria, the bifunctional adenylyltransferase GlnE is allosterically controlled by PII, such that its deadenylylation activity is stimulated when PII is uridylylated. Additionally, the metabolic transformation of PII by uridylyltransferase/uridylyl-removing enzyme (GlnD) provides a rapid switch to modulate deadenylylation in response to nitrogen availability. In eukaryotes, regulation of protein deadenylylation is less understood, but may involve similar sensor proteins and post-translational modifications.
protein deadenylylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| glnA | Cancer metabolism (glutamine addiction) | Cancer cell lines with GLUL knockout or overexpression |
| glnE | Bacterial infections (nitrogen assimilation) | Bacterial strains with glnE mutations; infection models |
| FICD | Neurodegeneration (ER stress) | Neuronal cell lines with FICD knockout or point mutations |
| glnB | Metabolic disorders (nitrogen imbalance) | Mouse models with PII mutations |
| glnD | Infectious diseases (regulatory pathway) | Bacterial knockout models |
Cancer Metabolism
Dysregulation of glutamine synthetase, the primary target of deadenylylation, has been implicated in cancer. Many tumors exhibit elevated glutamine synthetase activity to support rapid proliferation, and alterations in its regulation could contribute to oncogenesis. Although direct evidence for deadenylylation in cancer is limited, the role of glutamine metabolism in cancer makes this process a potential area of investigation.
Neurodegeneration
Protein AMPylation and deadenylylation have been linked to endoplasmic reticulum (ER) stress and neurodegeneration. The FICD protein, which AMPylates BiP, may also possess deadenylylation activity, and its dysfunction could contribute to protein misfolding diseases such as Alzheimer's and Parkinson's. Further research is needed to establish a direct link.
Infectious Diseases
Bacterial pathogens rely on nitrogen metabolism for survival and virulence. Inhibiting deadenylylation of glutamine synthetase could disrupt nitrogen assimilation, making it an attractive target for antibacterial drug development. Understanding the regulation of deadenylylation in pathogens may lead to new therapeutic strategies.
From protein deadenylylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of glnE affect deadenylylation? | Bacterial glnE knockout strain |
| What is the effect of point mutations in the active site of GlnE? | Site-directed mutagenesis in E. coli |
| Can we tag GlnE to visualize deadenylylation in real-time? | Knock-in of fluorescent tag (e.g., GFP) at glnE locus |
| Does overexpression of PII alter deadenylylation? | Plasmid-based overexpression in bacteria |
| Is FICD involved in protein deadenylylation in human cells? | CRISPR knockout of FICD in HEK293T cells |
| What is the role of deadenylylation in cancer metabolism? | Cancer cell lines with GLUL knockout/overexpression |
How to Study the protein deadenylylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro deadenylylation assay | Release of AMP from substrate | Enzyme kinetics and inhibitor screening |
| Gamma-glutamyltransferase assay | Glutamine synthetase activity | Assessing adenylylation state in bacteria |
| Mass spectrometry | Protein adenylylation levels and sites | Discovery of novel deadenylylation targets |
| CRISPR knockout | Loss-of-function phenotypes | Identifying gene function in deadenylylation |
| Site-directed mutagenesis | Role of specific residues | Mapping catalytic mechanism |
| Fluorescence microscopy | Localization and dynamics of enzymes | Live-cell imaging of deadenylylation |
| RNA-seq | Transcriptional changes upon deadenylylation | Global response to nitrogen status |
| Co-immunoprecipitation | Protein-protein interactions | Identifying regulatory complexes |
Biochemical Assays for Deadenylylation Activity
Deadenylylation activity can be measured using in vitro assays with purified enzymes and adenylylated substrate proteins. Typically, the release of AMP is quantified using radioactive labeling or fluorescent probes. For glutamine synthetase, the gamma-glutamyltransferase assay is commonly used to assess its adenylylation state.
Genetic Approaches: Knockouts and Mutants
Genetic knockout of key genes such as glnE or glnB in bacteria allows researchers to study the physiological consequences of loss of deadenylylation. Site-directed mutagenesis can identify critical residues in the active site of deadenylyltransferases. In eukaryotes, CRISPR-Cas9 knockout of candidate deadenylylases can reveal their roles in cellular processes.
Proteomic and Mass Spectrometry Analysis
Mass spectrometry can detect adenylylated proteins and map the specific modification sites. By comparing wild-type and mutant cells, researchers can identify proteins that undergo deadenylylation under different conditions. This approach is powerful for discovering novel targets of deadenylylation.
Imaging and Live-Cell Tracking
Fluorescent tagging of deadenylylation enzymes or substrate proteins enables real-time visualization of the process in live cells. For example, GFP-tagged GlnE can be used to monitor its localization and dynamics in response to nitrogen signals.
How CRISPR Can Be Used to Study GO:0044602 protein deadenylylation
Knockout
CRISPR-Cas9 knockout of genes involved in protein deadenylylation, such as glnE or FICD, allows researchers to study the loss-of-function phenotypes. In bacteria, glnE knockout results in the inability to regulate glutamine synthetase, leading to growth defects under nitrogen-limiting conditions. In human cells, FICD knockout can reveal its role in ER stress and protein folding.
Point Mutation
CRISPR-mediated point mutations can be introduced into the active sites of deadenylyltransferases to dissect their catalytic mechanism. For example, mutating the conserved histidine in GlnE can abolish deadenylylation activity while retaining adenylylation, helping to separate the two functions. Such models are valuable for understanding substrate specificity and regulation.
Knock-in
Knock-in of epitope tags or fluorescent proteins at endogenous loci enables real-time tracking of deadenylylation enzymes. Tagging GlnE with GFP in bacteria allows visualization of its localization and dynamics under different nitrogen conditions. In eukaryotes, knock-in of HA-tagged FICD can facilitate interaction studies.
Overexpression
Overexpression of deadenylylation enzymes or their regulators can amplify the process for biochemical analysis. For instance, overexpressing PII in bacteria enhances deadenylylation of glutamine synthetase, leading to increased enzyme activity. In mammalian cells, overexpression of candidate deadenylylases can help identify their substrates.
How EDITGENE Supports protein deadenylylation Research
Researchers studying protein deadenylylation-related genes often need to determine whether a candidate gene is causally involved in the process or contributes to disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for protein deadenylylation research.
Frequently Asked Questions About protein deadenylylation
What is protein deadenylylation?
Protein deadenylylation is the enzymatic removal of an adenylyl group (AMP) from a protein amino acid, reversing the effects of adenylylation.
What genes are involved in protein deadenylylation?
Key genes include glnE (bifunctional adenylyltransferase), glnB (PII regulatory protein), and glnD (uridylyltransferase) in bacteria, as well as FICD in eukaryotes.
How is protein deadenylylation regulated?
It is regulated by the PII protein, whose uridylylation state responds to nitrogen availability, and by metabolic signals such as glutamine and alpha-ketoglutarate.
What is the role of deadenylylation in glutamine synthetase regulation?
Deadenylylation activates glutamine synthetase, allowing nitrogen assimilation when nitrogen is abundant.
Is protein deadenylylation reversible?
Yes, it is reversible; adenylylation adds AMP, while deadenylylation removes it, allowing dynamic regulation.
What diseases are associated with protein deadenylylation?
Dysregulation may contribute to cancer metabolism, neurodegenerative diseases, and bacterial infections.
How can I study protein deadenylylation using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect gene function and regulation.
What methods are used to measure deadenylylation?
Biochemical assays, mass spectrometry, and fluorescence imaging are common methods.
What is the difference between protein deadenylylation and mRNA deadenylylation?
Protein deadenylylation removes AMP from proteins, while mRNA deadenylylation shortens the poly(A) tail of mRNA; they are distinct processes.
Which organisms have protein deadenylylation?
It is well-characterized in bacteria such as E. coli and Klebsiella, and emerging evidence suggests it occurs in eukaryotes.
Conclusion
Protein deadenylylation (GO:0044602) is a fundamental regulatory process that reverses protein adenylylation, with critical roles in bacterial nitrogen metabolism and potential implications in eukaryotic signaling and disease. The discovery of this process has illuminated the importance of reversible covalent modifications in cellular regulation. Continued research using advanced CRISPR models and biochemical techniques will further unravel its mechanisms and therapeutic potential.
References
- 1. Brown MS et al.. 1971. Modulation of glutamine synthetase adenylylation and deadenylylation is mediated by metabolic transformation of the P II -regulatory protein.. Proc Natl Acad Sci U S A 68(12):2949-53 PMID: 4399832
- 2. Anderson WB et al.. 1970. Association of ATP: glutamine synthetase adenylyltransferase activity with the P1 component of the glutamine synthetase deadenylylation system.. Proc Natl Acad Sci U S A 67(3):1417-24 PMID: 4249662
- 3. Mangum JH et al.. 1973. Regulation of glutamine synthetase adenylylation and deadenylylation by the enzymatic uridylylation and deuridylylation of the PII regulatory protein.. Arch Biochem Biophys 158(2):514-25 PMID: 4150122
- 4. Couttet P et al.. 1997. Messenger RNA deadenylylation precedes decapping in mammalian cells.. Proc Natl Acad Sci U S A 94(11):5628-33 PMID: 9159123
- 5. Greenberg ME et al.. 1990. Deadenylylation: a mechanism controlling c-fos mRNA decay.. Enzyme 44(1-4):181-92 PMID: 2133650
- 6. Jaggi R et al.. 1997. The two opposing activities of adenylyl transferase reside in distinct homologous domains, with intramolecular signal transduction.. EMBO J 16(18):5562-71 PMID: 9312015
- 8. Foor F et al.. 1980. Regulation of the synthesis of glutamine synthetase by the PII protein in Klebsiella aerogenes.. Proc Natl Acad Sci U S A 77(5):2636-40 PMID: 6104810
